Advanced search
Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 43, 2021 - Issue 12
Submit an article Journal homepage
234
Views
3
CrossRef citations to date
0
Altmetric
Original Research Paper

The effect of dexketoprofen trometamol on WAG/Rij rats with absence epilepsy (dexketoprofen in absence epilepsy)

Aras Erdila TR Ministry of Health, Sivas Dental Health Hospital, Sivas, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9582-5114View further author information
ORCID Icon,
Mustafa Sami Demirsoyb Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Sakarya University, Sakarya, TurkeyView further author information
,
Sefa Çolakc Private Practice, Tokat, TurkeyView further author information
,
Esra Dumand Department of Veterinary Medicine, Laboratory and Veterinary Health Program Vocational School University of Gazi Osmanpasa, Tokat, TurkeyView further author information
,
Orhan Sümbüle Department of Neurology, Faculty of Medicine University of Gaziosmanpasa, Tokat, TurkeyView further author information
&
Hatice Aygunf Department of Physiology, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, TurkeyORCID Iconhttps://orcid.org/0000-0002-4272-0562View further author information
ORCID Icon
Pages 1116-1125 | Received 02 Dec 2020, Accepted 01 Jul 2021, Published online: 18 Jul 2021

  • Srivastava A, Dixit AB, Banerjee J, et al. Role of inflammation and its miRNA based regulation in epilepsy: implications for therapy. Clin Chim Acta. 2016;452:1–9.
  • Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology. 2013;69(1):16–24.
  • Kandratavicius L, Balista P, Lopes-Aguiar C, et al. Neuropsychiatric disease and treatment Dovepress animal models of epilepsy: use and limitations. Neuropsychiatr Dis Treat. 2014;1693–1705. DOI:https://doi.org/10.2147/NDT.S50371.
  • Bayne T. The presence of consciousness in absence seizures. Behav Neurol. 2011;24(1):47–53.
  • Onat FY, van Luijtelaar G, Nehlig A, et al. The involvement of limbic structures in typical and atypical absence epilepsy. Epilepsy Res. 2013 Feb;103(2–3):111–123.
  • Perucca E, French J, Bialer M. Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol. 2007 Sep;6(9):793–804.
  • de Kinderen RJA, Evers SMAA, Rinkens R, et al. Side-effects of antiepileptic drugs: the economic burden. Seizure. 2014;23(3):184–190.
  • Luoni C, Bisulli F, Canevini MP, et al. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia. 2011 Dec;52(12):2181–2191.
  • Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004 Jul;5(7):553–564.
  • Pitkänen A, Sutula TP. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 2002;1(3):173–181.
  • Riazi K, Galic MA, Pittman QJ. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 2010 Mar;89(1):34–42.
  • Choi J, Nordli DR, Alden TD, et al. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation. 2009 Dec;6:38.
  • Riikonen R. Infantile spasms: therapy and outcome. J Child Neurol. 2004 Jun;19(6):401–404.
  • Wheless JW, Clarke DF, Arzimanoglou A, et al. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord. 2007 Dec;9(4):353–412.
  • Dubé CM, Brewster AL, Richichi C, et al. Fever, febrile seizures and epilepsy. Trends Neurosci. 2007 Oct;30(10):490–496.
  • Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res. 2004;10(4):201–222.
  • Kulkarni SK, Dhir A. Cyclooxygenase in epilepsy: from perception to application. Drugs Today (Barc). 2009 Feb;45(2):135–154.
  • Oliveira MS, Furian AF, Royes LFF, et al. Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures. Epilepsy Res. 2008 Mar;79(1):14–21.
  • Esparza-Villalpando V, Chavarria-Bolaños D, Gordillo-Moscoso A, et al. Comparison of the analgesic efficacy of preoperative/postoperative oral dexketoprofen trometamol in third molar surgery: a randomized clinical trial. J Cranio-Maxillofacial Surg. 2016;44(9):1350–1355.
  • Eroglu CN, Ataoglu H, Yildirim G, et al. Comparison of the efficacy of low doses of methylprednisolone, acetaminophen, and dexketoprofen trometamol on the swelling developed after the removal of impacted third molar. Med Oral Patol Oral Cir Bucal. 2015;20(5):e627–e632.
  • Isiordia-Espinoza MA, Pozos-Guillen A, Martinez-Rider R, et al. Comparison of the analgesic efficacy of oral ketorolac versus intramuscular tramadol after third molar surgery: a parallel, double-blind, randomized, placebo-controlled clinical trial. Med Oral Patol Oral Cir Bucal. 2016;21(5):e637–e643.
  • Ong CKS, Seymour RA. Pathogenesis of postoperative oral surgical pain. Anesth Prog. 2003 Dec;50(1):5–17.
  • Lee Y, Rodriguez C, Dionne R. The role of COX-2 in acute pain and the use of selective COX-2 inhibitors for acute pain relief. Curr Pharm Des. 2005 Apr;11(14):1737–1755.
  • Costa FWG, Esses DFS, De Barros Silva PG, et al. Does the preemptive use of oral nonsteroidal anti-inflammatory drugs reduce postoperative pain in surgical removal of third molars? A meta-analysis of randomized clinical trials. Anesth Prog. 2015;62(2):57–63.
  • Bagán JV, López Arranz JS, Valencia E, et al. Clinical comparison of dexketoprofen trometamol and dipyrone in postoperative dental pain. J Clin Pharmacol. 1998;38(S1):55S–64S.
  • Sweetman BJ. Development and use of the quick acting chiral NSAID dexketoprofen trometamol (keral). Acute Pain. 2003;4(3–4):109–115.
  • Barbanoj Rodríguez MJ, Antonijoan Arbós RM, Amaro SR. Dexketoprofen trometamol: clinical evidence supporting its role as a painkiller. Expert Rev Neurother. 2008 Nov;8(11):1625–1640.
  • Russo E, Citraro R, Constanti A, et al. Upholding WAG/Rij rats as a model of absence epileptogenesis: hidden mechanisms and a new theory on seizure development. Neurosci Biobehav Rev. 2016 Dec;71:388–408.
  • van Luijtelaar G, Sitnikova E. Global and focal aspects of absence epilepsy: the contribution of genetic models. Neurosci Biobehav Rev. 2006;30(7):983–1003.
  • van Luijtelaar G, Zobeiri M. Progress and outlooks in a genetic absence epilepsy model (WAG/Rij. Curr Med Chem. 2014;21(6):704–721.
  • Sarkisova K, van Luijtelaar G. The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression [corrected]. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun;35(4):854–876.
  • Citraro R, Chimirri S, Aiello R, et al. Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy. Epilepsia. 2014 Aug;55(8):1284–1291.
  • van Luijtelaar G, van Oijen G. Establishing drug effects on electrocorticographic activity in a genetic absence epilepsy model: advances and pitfalls. Front Pharmacol. 2020;11:395.
  • Aygun H. Trazodone increases seizures in a genetic WAG/Rij rat model of absence epilepsy while decreasing them in penicillin-evoked focal seizure model. Epilepsy Behav. 2020;103(xxxx):106847.
  • Coenen AM, Drinkenburg WH, Inoue M, et al. Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats. Epilepsy Res. 1992 Jul;12(2):75–86.
  • Erbaş O, Solmaz V, Aksoy D. Inhibitor effect of dexketoprofen in rat model of pentylenetetrazol-induced seizures. Neurol Res. 2015;37(12):1096–1101.
  • Dhir A, Naidu PS, Kulkarni SK. Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: possible mechanism of action. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec;30(8):1478–1485.
  • Maroso M, Balosso S, Ravizza T, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med. 2010 Apr;16(4):413–419.
  • Vezzani A, French J, Bartfai T, et al. The role of inflammation in epilepsy. Nat Rev Neurol. 2011 Jan;7(1):31–40.
  • Farkhondeh T, Samarghandian S, Shaterzadeh Yazdi H, et al. The protective effects of crocin in the management of neurodegenerative diseases: a review. Am J Neurodegener Dis. 2018;7(1):1–10.
  • Dey A, Kang X, Qiu J, et al. Anti-inflammatory small molecules to treat seizures and epilepsy: from bench to bedside. Trends Pharmacol Sci. 2016 Jun;37(6):463–484.
  • Wang Z-H, Mong M-C, Yang Y-C, et al. Asiatic acid and maslinic acid attenuated kainic acid-induced seizure through decreasing hippocampal inflammatory and oxidative stress. Epilepsy Res. 2018 Jan;139:28–34.
  • Rojas A, Jiang J, Ganesh T, et al. Cyclooxygenase-2 in epilepsy. Epilepsia. 2014 Jan;55(1):17–25.
  • van Luijtelaar G, Lyashenko S, Vastyanov R, et al. Cytokines and absence seizures in a genetic rat model. Neurophysiology. 2012;43(6):478–486.
  • Russo E, Andreozzi F, Iuliano R, et al. Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release. Brain Behav Immun. 2014 Nov;42:157–168.
  • Kovács Z, Dobolyi A, Juhász G, et al. Lipopolysaccharide induced increase in seizure activity in two animal models of absence epilepsy WAG/Rij and GAERS rats and Long Evans rats. Brain Res Bull. 2014 May;104:7–18.
  • Kovács Z, Czurkó A, Kékesi KA, et al. Intracerebroventricularly administered lipopolysaccharide enhances spike-wave discharges in freely moving WAG/Rij rats. Brain Res Bull. 2011 Jul;85(6):410–416.
  • Rimoli MG, Russo E, Cataldi M, et al. T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin. Neuropharmacology. 2009 Mar;56(3):637–646.
  • Citraro R, Leo A, De Fazio P, et al. Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy. BrJ Pharmacol. 2015 Jun;172(12):3177–3188.
  • McGurk M, Robinson P, Rajayogeswaran V, et al. Clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo in postoperative dental pain. J Clin Pharmacol. 1998 Dec;38(S1):46S–54S.
  • Iohom G, Walsh M, Higgins G, et al. Effect of perioperative administration of dexketoprofen on opioid requirements and inflammatory response following elective hip arthroplasty. Br J Anaesth. 2002 Apr;88(4):520–526.
  • Jamali F, Brocks DR. Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet. 1990 Sep;19(3):197–217.
  • Velioglu SK, Gedikli O, Yıldırım M, et al. Epilepsy may cause increased pain sensitivity: evidence from absence epileptic WAG/Rij rats. Epilepsy Behav. 2017 Oct;75:146–150.
  • Radu BM, Epureanu FB, Radu M, et al. Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy. Epilepsy Res. 2017;131:15–27.
  • Kaminski R, Kozicka M, Parada-Turska J, et al. Effect of non-steroidal anti-inflammatory drugs on the anticonvulsive activity of valproate and diphenylhydantoin against maximal electroshock-induced seizures in mice. Pharmacol Res. 1998 May;37(5):375–381.
  • Matthews ML. The role of dose reduction with NSAID use. Am J Manag Care. 2013 Nov;19(14 Suppl):s273–7.
  • Kawada N, Moriyama T, Kitamura H, et al. Towards developing new strategies to reduce the adverse side-effects of nonsteroidal anti-inflammatory drugs. Clin Exp Nephrol. 2012 Feb;16(1):25–29.
  • Paudel YN, Shaikh MF, Shah S, et al. Role of inflammation in epilepsy and neurobehavioral comorbidities: implication for therapy. Eur J Pharmacol. 2018;837:145–155.
  • Sarkisova KY, Gabova AV. Maternal care exerts disease-modifying effects on genetic absence epilepsy and comorbid depression. Genes, Brain Behav. 2018;17(7):1–14.
  • Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013 Sep;11(1):200.
  • Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007;30(7):555–567. New Zealand.
  • Greer JM, Capecchi MR. Hoxb8 is required for normal grooming behavior in mice. Neuron. 2002 Jan;33(1):23–34.
  • Eguibar JR, Romero-Carbente JC, Moyaho A. Behavioral differences between selectively bred rats: D1 versus D2 receptors in yawning and grooming. Pharmacol Biochem Behav. 2003 Mar;74(4):827–832.
  • Kalueff AV, Tuohimaa P. The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress research. J Neurosci Methods. 2005 Apr;143(2):169–177.
  • Kompagne H, Bárdos G, Szénási G, et al. Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats. Behav Brain Res. 2008 Nov;193(2):311–314.
  • Escorihuela RM, Fernández-Teruel A, Gil L, et al. Inbred Roman high- and low-avoidance rats: differences in anxiety, novelty-seeking, and shuttlebox behaviors. Physiol Behav. 1999 Aug;67(1):19–26.
  • Willner P, Mitchell PJ. The validity of animal models of predisposition to depression. Behav Pharmacol. 2002 May;13(3):169–188.
  • Sarkisova KY, Kulikov MA, Midzyanovskaya IS, et al. Dopamine-dependent nature of depression-like behavior in WAG/Rij rats with genetic absence epilepsy. Neurosci Behav Physiol. 2008 Feb;38(2):119–128.
  • Russo E, Citraro R, Davoli A, et al. Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology. 2013 Jan;64:371–379.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.